2310-C EXACERBATION OF LIVER INJURY IN A MOUSE MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE THROUGH INDUCTION OF GUT FUNGAL DYSBIOSIS Vijay Pandyarajan, Cedars-Sinai Medical Center, Los Angeles, CA and Ekihiro Seki, Cedars-Sinai Medical Center, Torrance, CA Background: Non-alcoholic fatty liver disease (NAFLD) is projected to become the leading cause for liver transplantation within the next 30 years
Se aplican costos adicionales, que incluyen una revisin mdica, apoyo del proveedor y manejo de efectos secundarios
The drug prescribed for weight loss purposes for adults who have a high body mass index (BMI) and may benefit from losing weight, regardless of whether they have diabetes or not
Although astrocyte reactivity serves as an initial defensive mechanism, excessive or prolonged reactivity has been implicated in the progression of neurodegenerative diseases
Unfortunately, they are being offered in unregulated, unsterile environments without proper clinical oversight